Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-06-23 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于公开发行可转换公司债券预案修订情况说明的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the revision of a convertible bond issuance plan by the company 三诺生物传感股份有限公司. It references board meetings, shareholder meetings, and regulatory changes affecting the issuance plan. The document includes explanations of revisions to the bond issuance proposal and financial information updates related to the issuance. The text is relatively short (1416 characters) and primarily serves as a public announcement of changes to a financing plan rather than the full detailed financing report itself. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-06-23 Chinese
第四届监事会第五次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fifth meeting of the fourth Supervisory Board of SanNuo Biological Sensor Co., Ltd. It details the approval of various proposals related to the company's public issuance of convertible bonds, including compliance with relevant laws and regulations, revisions to issuance plans, and confirmation of the accuracy and completeness of the prospectus. The document is an official meeting resolution announcement rather than a full report or financial statement. It does not contain financial data or detailed analysis but rather the outcomes of supervisory board deliberations and approvals. The document length is relatively short (2389 characters), and it serves as a formal disclosure of meeting decisions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-06-23 Chinese
可转换公司债券持有人会议规则（2020年6月）
Governance Information Classification · 95% confidence The document is titled "三诺生物传感股份有限公司 可转换公司债券持有人会议规则（修订稿）" which translates to "SanNuo Biological Sensor Co., Ltd. Convertible Corporate Bondholders Meeting Rules (Revised Edition)". It details the rules, rights, obligations, procedures, and governance related to meetings of holders of the company's convertible bonds. The content is regulatory and procedural in nature, focusing on bondholder meetings, voting rights, meeting convocations, and legal compliance. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an announcement of a report but a detailed governance document related to bondholder meetings. This fits best under Governance Information (CGR), which covers internal rules and governance practices of the company, including bondholder meeting rules and procedures.
2020-06-23 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the seventh meeting of the fourth board of directors of 三诺生物传感股份有限公司 (Sinocare Inc.). It details the meeting date, attendance, and the voting results on several proposals related to the company's qualification and plans for issuing convertible bonds. The document includes references to independent directors' opinions and mentions that the board meeting was authorized by a prior shareholders' meeting, so no further shareholder approval is needed. The content focuses on board decisions and approvals rather than financial results, earnings, or detailed financial statements. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is not a proxy solicitation or voting results announcement. The document is a formal board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 2339 characters, which is consistent with a meeting resolution announcement rather than a full report.
2020-06-23 Chinese
公开发行可转换公司债券方案的论证分析报告（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "论证分析报告" (Demonstration and Analysis Report) for the public issuance of convertible corporate bonds by Sinocare Inc. It discusses the necessity, feasibility, pricing, issuance method, and impact on shareholders of the convertible bonds. The content is detailed and technical, focusing on the issuance of convertible bonds, their pricing, legal compliance, and financial impact. It is not a general annual or quarterly financial report, nor is it an announcement or a brief summary. It is a comprehensive report analyzing the convertible bond issuance plan, which fits the category of Capital/Financing Update (CAP).
2020-06-23 Chinese
关于公司董事、高级管理人员减持计划实施完毕的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the completion of share reduction plans by company directors and senior management. It details the number of shares reduced, the timing, and compliance with relevant regulations. It does not contain financial statements or detailed financial performance data. The document is focused on insider share transactions by directors and executives, specifically their shareholding reductions. Therefore, it fits the category of Director's Dealing (DIRS). The document length is under 5,000 characters and is a formal announcement of insider share transactions, not a full report or financial disclosure.
2020-06-16 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.